Claire Klopfenstein
Chief Executive Officer at Pharmaster + SAS
Profile
Claire Klopfenstein is currently the Chief Executive Officer at Pharmaster + SAS since 2019.
Prior to this, she worked as the Managing Director-Pharmaster at Financière SynerLAB SAS.
Claire Klopfenstein active positions
| Companies | Position | Start |
|---|---|---|
Pharmaster + SAS
 Pharmaster + SAS Pharmaceuticals: MajorHealth Technology Pharmaster Plus SAS manufactures sterile liquid products and offers preservative free solutions. It offers ophthalmic, ear and nasal devices and also provides aseptic liquid filling in multidose format glass and plastic bottles. The company was founded in 1989 and is headquartered in Erstein, France. | Chief Executive Officer | 2019-03-07 |
Former positions of Claire Klopfenstein
| Companies | Position | End |
|---|---|---|
Financière SynerLAB SAS
 Financière SynerLAB SAS Pharmaceuticals: MajorHealth Technology Financière SynerLAB SAS manufactures pharmaceutical products. It offers liquid, solid, beta-lactam and sterile formed products. The company was founded in 2001 and is headquartered in Entzheim, France. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Financière SynerLAB SAS
Financière SynerLAB SAS Pharmaceuticals: MajorHealth Technology Financière SynerLAB SAS manufactures pharmaceutical products. It offers liquid, solid, beta-lactam and sterile formed products. The company was founded in 2001 and is headquartered in Entzheim, France. | Health Technology |
Pharmaster + SAS
Pharmaster + SAS Pharmaceuticals: MajorHealth Technology Pharmaster Plus SAS manufactures sterile liquid products and offers preservative free solutions. It offers ophthalmic, ear and nasal devices and also provides aseptic liquid filling in multidose format glass and plastic bottles. The company was founded in 1989 and is headquartered in Erstein, France. | Health Technology |
- Stock Market
- Insiders
- Claire Klopfenstein
